{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:45:42Z","timestamp":1780393542908,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["C2021088"],"award-info":[{"award-number":["C2021088"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202201020644"],"award-info":[{"award-number":["202201020644"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2024A04J10030"],"award-info":[{"award-number":["2024A04J10030"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clim.2025.110638","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:34:13Z","timestamp":1762482853000},"page":"110638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Serum cytokine profiling identifies IL-17A and IL-10 as prognostic biomarkers for disease outcome in pediatric acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"282","author":[{"given":"Qian","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huishan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","article-title":"Genetics and prognosis of ALL in children vs adults","volume":"2018","author":"Roberts","year":"2018","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/asheducation-2018.1.25","article-title":"No free rides: management of toxicities of novel immunotherapies in ALL, including financial","volume":"2018","author":"Jain","year":"2018","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.clim.2025.110638_bb0015","series-title":"StatPearls","article-title":"Acute lymphocytic leukemia","author":"Puckett","year":"2024"},{"issue":"11","key":"10.1016\/j.clim.2025.110638_bb0020","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic Leukemia, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"12","key":"10.1016\/j.clim.2025.110638_bb0030","article-title":"A review of acute lymphocytic leukemia (ALL) in the Pediatric population: evaluating current trends and changes in guidelines in the past decade","volume":"15","author":"Ekpa","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s42003-023-04897-w","article-title":"Multi-omics delineation of cytokine-induced endothelial inflammatory states","volume":"6","author":"Groten","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.clim.2025.110638_bb0040","series-title":"Encyclopedia of Cancer (Second Edition)","first-page":"523","article-title":"Interleukins","author":"Hodi","year":"2002"},{"key":"10.1016\/j.clim.2025.110638_bb0045","series-title":"The Cytokines of the Immune System","first-page":"143","article-title":"Chapter 6 - Cytokines of the immune system: Interleukins","author":"Dembic","year":"2015"},{"issue":"3","key":"10.1016\/j.clim.2025.110638_bb0050","first-page":"231","article-title":"Proinflammatory cytokine interleukin-6 in prostate carcinogenesis","volume":"2","author":"Culig","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.clim.2025.110638_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.872010","article-title":"Cytokine based immunotherapy for cancer and lymphoma: biology, challenges and future perspectives","volume":"13","author":"Atallah-Yunes","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2025.110638_bb0060","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/ijms24044002","article-title":"Crosstalk of inflammatory cytokines within the breast tumor microenvironment","volume":"24","author":"Habanjar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.clim.2025.110638_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030607","article-title":"The role of cytokines and chemokines in shaping the immune microenvironment of glioblastoma: implications for immunotherapy","volume":"10","author":"Yeo","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.clim.2025.110638_bb0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0885-3924(00)00199-8","article-title":"Cytokines and advanced cancer","volume":"20","author":"Dunlop","year":"2000","journal-title":"J. Pain Symptom Manag."},{"issue":"7","key":"10.1016\/j.clim.2025.110638_bb0075","first-page":"2702","article-title":"Serum interleukin 6 as a prognostic factor in patients with prostate cancer","volume":"6","author":"Nakashima","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.clim.2025.110638_bb0080","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1158\/1078-0432.CCR-04-0812","article-title":"Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival","volume":"10","author":"Benoy","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2025.110638_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.clim.2025.110638_bb0090","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1002\/cam4.2327","article-title":"Crosstalk between cancer and immune cells: role of tumor-associated macrophages in the tumor microenvironment","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.clim.2025.110638_bb0095","article-title":"Immunotherapy for Pediatric acute lymphoblastic Leukemia: recent advances and future perspectives","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2025.110638_bb0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/j.1460-2075.1994.tb06300.x","article-title":"A common factor regulates both Th1- and Th2-specific cytokine gene expression","volume":"13","author":"Rooney","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2025.110638_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156267","article-title":"Cytokine network imbalance in children with B-cell acute lymphoblastic leukemia at diagnosis","volume":"169","author":"Dai","year":"2023","journal-title":"Cytokine"},{"issue":"15","key":"10.1016\/j.clim.2025.110638_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512323","article-title":"Significance of Th17And Treg in treatment efficacy and outcome in Pediatric acute lymphoblastic Leukemia","volume":"24","author":"Kr\u0119towska-Grunwald","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.clim.2025.110638_bb0115","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ejso.2021.04.011","article-title":"When to consider logistic LASSO regression in multivariate analysis?","volume":"47","author":"Hu","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.clim.2025.110638_bb0120","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3324\/haematol.2022.280638","article-title":"Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients","volume":"107","author":"Saygin","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.clim.2025.110638_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/leu.2016.234","article-title":"Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with response-adapted therapy","volume":"31","author":"Pui","year":"2017","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.clim.2025.110638_bb0130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","article-title":"Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003","volume":"124","author":"O\u2019Connor","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clim.2025.110638_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.26444\/jpccr\/175214","article-title":"Treatment-related mortality in the course of acute lymphoblastic leukemia \u2013 case report","volume":"17","author":"Bigosi\u0144ski","year":"2023","journal-title":"J. Pre-Clin. Clin. Res."},{"issue":"5","key":"10.1016\/j.clim.2025.110638_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000087104","article-title":"Cytokine dysregulation, inflammation and well-being","volume":"12","author":"Elenkov","year":"2005","journal-title":"Neuroimmunomodulation"},{"issue":"12","key":"10.1016\/j.clim.2025.110638_bb0145","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41590-019-0557-0","article-title":"Cytokines in the balance","volume":"20","year":"2019","journal-title":"Nat. Immunol."},{"issue":"47","key":"10.1016\/j.clim.2025.110638_bb0150","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/sj.onc.1210758","article-title":"Aberrant cytokine signaling in leukemia","volume":"26","author":"Van Etten","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2025.110638_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/09511920410001713574","article-title":"Granulocyte colony-stimulating factor and leukemogenesis","volume":"13","author":"de Figueiredo","year":"2004","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.clim.2025.110638_bb0160","first-page":"249","article-title":"A study of the effects of chemotherapy with or without G-CSF on neutrophil counts and serum G-CSF levels in leukemia patients","volume":"35","author":"Chen","year":"1996","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"8","key":"10.1016\/j.clim.2025.110638_bb0165","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/cas.12459","article-title":"Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia","volume":"105","author":"Han","year":"2014","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.clim.2025.110638_bb0170","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.3892\/or.2016.4657","article-title":"Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection","volume":"35","author":"P\u00e9rez-Figueroa","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.clim.2025.110638_bb0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-015-0590-1","article-title":"IL-17\/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia","volume":"13","author":"Musuraca","year":"2015","journal-title":"J. Transl. Med."},{"issue":"26","key":"10.1016\/j.clim.2025.110638_bb0180","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1182\/blood-2009-10-246660","article-title":"Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma","volume":"115","author":"Prabhala","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12935-022-02528-8","article-title":"The role of Th17 cells in the pathogenesis and treatment of breast cancer","volume":"22","author":"Karpisheh","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"27","key":"10.1016\/j.clim.2025.110638_bb0190","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"De Simone","year":"2015","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.clim.2025.110638_bb0195","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"9999","key":"10.1016\/j.clim.2025.110638_bb0200","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12967-016-0894-9","article-title":"Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling","volume":"14","author":"Bi","year":"2016","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008390-199502000-00008","article-title":"Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma","volume":"5","author":"Dummer","year":"1995","journal-title":"Melanoma Res."},{"issue":"6","key":"10.1016\/j.clim.2025.110638_bb0215","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.18632\/oncotarget.23385","article-title":"Synthetic analysis of associations between IL-10 polymorphisms and skin cancer risk","volume":"9","author":"Zhao","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.clim.2025.110638_bb0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10120-009-0509-8","article-title":"Serum interleukin-6 and -10 levels in patients with gastric cancer","volume":"12","author":"Ikeguchi","year":"2009","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.clim.2025.110638_bb0225","first-page":"759","article-title":"Laboratory evaluation of TGFbeta1, IL-10, VEGF levels in vivo and in vitro in patients with solid tumors","volume":"57","author":"Danilova","year":"2011","journal-title":"Vopr. Onkol."},{"issue":"3","key":"10.1016\/j.clim.2025.110638_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002770050564","article-title":"Poor clinical outcome of patients with Hodgkin\u2019s disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin\u2019s disease","volume":"79","author":"Bohlen","year":"2000","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.clim.2025.110638_bb0235","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.2016.11","article-title":"High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma","volume":"114","author":"Wang","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.clim.2025.110638_bb0240","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1182\/bloodadvances.2021005522","article-title":"Decreased IL-10 accelerates B-cell leukemia\/lymphoma in a mouse model of pediatric lymphoid leukemia","volume":"6","author":"Fitch","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.clim.2025.110638_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156371","article-title":"A dual-role for IL-10: from leukemogenesis to the tumor progression in acute lymphoblastic leukemia","volume":"171","author":"Silva","year":"2023","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41467-023-44270-3","article-title":"Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.clim.2025.110638_bb0255","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190297","article-title":"The role of interleukin-17 in tumor development and progression","volume":"217","author":"Zhao","year":"2019","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162500213X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162500213X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:31Z","timestamp":1778616211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162500213X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"alternative-id":["S152166162500213X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110638","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cytokine profiling identifies IL-17A and IL-10 as prognostic biomarkers for disease outcome in pediatric acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110638"}}